Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline Hydrochloride Foam for Moderate-to-Severe Acne Vulgaris
CTR20260371Phase 3Active
- Sponsor
- Zezheng Pharmaceutical
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of minocycline in acne vulgaris, sponsored by Zezheng Pharmaceutical. Started Feb 2026; status: active.
02
Drugs
minocycline
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on CTR20260371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260371.